首页 > 最新文献

Seminars in Cardiothoracic and Vascular Anesthesia最新文献

英文 中文
Retracted: "The Impact of Dexmedetomidine Infusion in Sparing Morphine Consumption in Off-Pump Coronary Artery Bypass Grafting". 收回:“右美托咪定输注对非体外循环冠状动脉搭桥术中减少吗啡消耗的影响”。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-09-01 Epub Date: 2023-05-30 DOI: 10.1177/10892532231179573
{"title":"Retracted: \"The Impact of Dexmedetomidine Infusion in Sparing Morphine Consumption in Off-Pump Coronary Artery Bypass Grafting\".","authors":"","doi":"10.1177/10892532231179573","DOIUrl":"10.1177/10892532231179573","url":null,"abstract":"","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"244"},"PeriodicalIF":1.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9541477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-Guided Radial Arterial Catheterization in Patients With Regurgitant and Stenotic Left-Sided Cardiac Valvular Lesions. 超声引导下左心瓣膜返流性和狭窄性病变患者的桡动脉插管。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-09-01 Epub Date: 2023-06-02 DOI: 10.1177/10892532231181481
C M Rakhi Krishna, Sandeep Kumar Mishra, Ajay Kumar Jha, Muthapillai Senthilnathan, Satyen Parida

Background. The pulse characteristics of arterial circulation might affect radial artery catheterization's success rate. Therefore, we hypothesized that the success rate of radial artery catheterization would be lower in the left-sided severe stenotic valvular lesion group than severe regurgitant valvular lesion group. Methods. This prospective study was conducted among patients with left-sided cardiac valvular lesions undergoing cardiac and non-cardiac surgery. The patients with left-sided severe valvular stenosis and left-sided severe valvular regurgitation were included in the study. Radial artery cannulation was performed using an ultrasound-guided out-of-plane short-axis approach. The outcome measures were success rate, number of attempts, and cannulation time. Result. One hundred fifty-two patients were recruited for the study, and all were eligible for final analysis. The first attempt success rate was non-significantly higher in the stenotic valvular lesion group than the regurgitant group (69.7% vs 56.6%; P = .09). Furthermore, the number of attempts (median; 95% CI) was significantly higher in the regurgitant group (1; 1.2-1.43 vs 1; 1.38-1.67; P = .04). However, it may not be of clinical relevance. Moreover, the cannulation time and the number of redirections of the cannula were comparable. Heart rate was significantly higher in the regurgitant group (91.8 ± 13.9 vs 82.26 ± 15.92 beats/min; P = .00), while the incidence of atrial fibrillation was significantly higher in the stenotic lesion (P = .00). No failure was reported, and the incidence of periarterial hematoma was comparable. Conclusion. The success rate of ultrasound-guided radial arterial catheterization is comparable in left-sided stenotic valvular and regurgitant lesion groups.

背景动脉循环的脉冲特征可能影响桡动脉插管的成功率。因此,我们假设左侧严重狭窄瓣膜病变组的桡动脉插管成功率低于严重反流瓣膜病变组。方法。这项前瞻性研究是在接受心脏和非心脏手术的左侧心瓣膜病变患者中进行的。左侧严重瓣膜狭窄和左侧严重瓣膜反流的患者被纳入研究。桡动脉插管采用超声引导平面外短轴入路。结果指标包括成功率、尝试次数和插管时间。后果152名患者被招募参加这项研究,所有患者都有资格进行最终分析。狭窄瓣膜病变组的首次尝试成功率并不显著高于反流组(69.7%vs 56.6%;P=0.09)。此外,反流组的尝试次数(中位数;95%CI)显著较高(1;1.2-1.43vs 1;1.38-1.67;P=0.04)。然而,这可能与临床无关。此外,插管时间和插管重定向次数是可比较的。反流组的心率明显较高(91.8±13.9 vs 82.26±15.92次/分;P=0.00),而狭窄病变的心房颤动发生率明显较高(P=0.00)。没有失败报告,动脉周围血肿的发生率相当。结论在左侧狭窄瓣膜病变组和反流病变组中,超声引导下桡动脉插管的成功率相当。
{"title":"Ultrasound-Guided Radial Arterial Catheterization in Patients With Regurgitant and Stenotic Left-Sided Cardiac Valvular Lesions.","authors":"C M Rakhi Krishna,&nbsp;Sandeep Kumar Mishra,&nbsp;Ajay Kumar Jha,&nbsp;Muthapillai Senthilnathan,&nbsp;Satyen Parida","doi":"10.1177/10892532231181481","DOIUrl":"10.1177/10892532231181481","url":null,"abstract":"<p><p><i>Background.</i> The pulse characteristics of arterial circulation might affect radial artery catheterization's success rate. Therefore, we hypothesized that the success rate of radial artery catheterization would be lower in the left-sided severe stenotic valvular lesion group than severe regurgitant valvular lesion group. <i>Methods.</i> This prospective study was conducted among patients with left-sided cardiac valvular lesions undergoing cardiac and non-cardiac surgery. The patients with left-sided severe valvular stenosis and left-sided severe valvular regurgitation were included in the study. Radial artery cannulation was performed using an ultrasound-guided out-of-plane short-axis approach. The outcome measures were success rate, number of attempts, and cannulation time. <i>Result.</i> One hundred fifty-two patients were recruited for the study, and all were eligible for final analysis. The first attempt success rate was non-significantly higher in the stenotic valvular lesion group than the regurgitant group (69.7% vs 56.6%; <i>P</i> = .09). Furthermore, the number of attempts (median; 95% CI) was significantly higher in the regurgitant group (1; 1.2-1.43 vs 1; 1.38-1.67; <i>P</i> = .04). However, it may not be of clinical relevance. Moreover, the cannulation time and the number of redirections of the cannula were comparable. Heart rate was significantly higher in the regurgitant group (91.8 ± 13.9 vs 82.26 ± 15.92 beats/min; <i>P</i> = .00), while the incidence of atrial fibrillation was significantly higher in the stenotic lesion (<i>P</i> = .00). No failure was reported, and the incidence of periarterial hematoma was comparable. <i>Conclusion.</i> The success rate of ultrasound-guided radial arterial catheterization is comparable in left-sided stenotic valvular and regurgitant lesion groups.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"153-161"},"PeriodicalIF":1.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9569324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Opioid-free anesthesia versus opioid-based anesthesia in patients undergoing cardiovascular and thoracic surgery: a meta-analysis and systematic review. 心血管和胸部手术患者的无阿片类药物麻醉与基于阿片类物质的麻醉:一项荟萃分析和系统综述。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-09-01 Epub Date: 2023-06-10 DOI: 10.1177/10892532231180227
Dave M Mathew, Peter J Fusco, Kathryn S Varghese, Ahmed K Awad, Eamon Vega, Serena M Mathew, Mia Polizzi, Jerrin George, Christopher S Mathew, Jeremiah J Thomas, Rose Calixte, Adham Ahmed

Background: Despite their extensive clinical use, opioids are characterized by several side effects. These complications, coupled with the ongoing opioid epidemic, have favored the rise of opioid-free-anesthesia (OFA). Herein, we perform the first pairwise meta-analysis of clinical outcomes for OFA vs opioid-based anesthesia (OBA) in patients undergoing cardiovascular and thoracic surgery.

Methods: We comprehensively searched medical databases to identify studies comparing OFA and OBA in patients undergoing cardiovascular or thoracic surgery. Pairwise meta-analysis was performed using the Mantel-Haenszel method. Outcomes were pooled as risk ratios (RR) or standard mean differences (SMD) and their 95% confidence intervals (95% CI).

Results: Our pooled analysis included 919 patients (8 studies), of whom 488 underwent surgery with OBA and 431 with OFA. Among cardiovascular surgery patients, compared to OBA, OFA was associated with significantly reduced post-operative nausea and vomiting (RR, 0.57; P = .042), inotrope need (RR .84, P = .045), and non-invasive ventilation (RR, .54; P = .028). However, no differences were observed for 24hr pain score (SMD, -.35; P = .510) or 48hr morphine equivalent consumption (SMD, -1.09; P = .139). Among thoracic surgery patients, there was no difference between OFA and OBA for any of the explored outcomes, including post-operative nausea and vomiting (RR, 0.41; P = .025).

Conclusion: Through the first pooled analysis of OBA vs OFA in a cardiothoracic-exclusive cohort, we found no significant difference in any of the pooled outcomes for thoracic surgery patients. Although limited to 2 cardiovascular surgery studies, OFA was associated with significantly reduced postoperative nausea and vomiting, inotrope need, and non-invasive ventilation in these patients. With growing use of OFA in invasive operations, further studies are needed to assess their efficacy and safety in cardiothoracic patients.

背景:尽管阿片类药物在临床上应用广泛,但其特点是有几种副作用。这些并发症,加上持续的阿片类药物流行,有利于无阿片类麻醉(OFA)的兴起。在此,我们对接受心血管和胸部手术的患者的OFA与阿片类药物麻醉(OBA)的临床结果进行了首次成对荟萃分析。方法:我们全面检索医学数据库,以确定在接受心血管或胸部手术的患者中比较OFA和OBA的研究。使用Mantel Haenszel方法进行配对荟萃分析。结果汇总为风险比(RR)或标准平均差(SMD)及其95%置信区间(95%CI)。结果:我们的汇总分析包括919名患者(8项研究),其中488人接受了OBA手术,431人接受了OFA手术。在心血管手术患者中,与OBA相比,OFA与术后恶心和呕吐(RR,0.57;P=.042)、inotrope需求(RR.84,P=.045)和无创通气(RR,.54;P=.028)显著减少有关。然而,24小时疼痛评分(SMD,-0.35;P=.510)或48小时吗啡当量消耗量(SMD:-1.09;P=.139)没有观察到差异。在胸部手术患者中,OFA和OBA之间的任何探索结果都没有差异,包括术后恶心和呕吐(RR,0.41;P=0.025)。尽管仅限于2项心血管手术研究,但OFA与这些患者术后恶心和呕吐、inotrope需求和无创通气显著减少有关。随着OFA在侵入性手术中的应用越来越多,需要进一步的研究来评估其在心胸外科患者中的疗效和安全性。
{"title":"Opioid-free anesthesia versus opioid-based anesthesia in patients undergoing cardiovascular and thoracic surgery: a meta-analysis and systematic review.","authors":"Dave M Mathew, Peter J Fusco, Kathryn S Varghese, Ahmed K Awad, Eamon Vega, Serena M Mathew, Mia Polizzi, Jerrin George, Christopher S Mathew, Jeremiah J Thomas, Rose Calixte, Adham Ahmed","doi":"10.1177/10892532231180227","DOIUrl":"10.1177/10892532231180227","url":null,"abstract":"<p><strong>Background: </strong>Despite their extensive clinical use, opioids are characterized by several side effects. These complications, coupled with the ongoing opioid epidemic, have favored the rise of opioid-free-anesthesia (OFA). Herein, we perform the first pairwise meta-analysis of clinical outcomes for OFA vs opioid-based anesthesia (OBA) in patients undergoing cardiovascular and thoracic surgery.</p><p><strong>Methods: </strong>We comprehensively searched medical databases to identify studies comparing OFA and OBA in patients undergoing cardiovascular or thoracic surgery. Pairwise meta-analysis was performed using the Mantel-Haenszel method. Outcomes were pooled as risk ratios (RR) or standard mean differences (SMD) and their 95% confidence intervals (95% CI).</p><p><strong>Results: </strong>Our pooled analysis included 919 patients (8 studies), of whom 488 underwent surgery with OBA and 431 with OFA. Among cardiovascular surgery patients, compared to OBA, OFA was associated with significantly reduced post-operative nausea and vomiting (RR, 0.57; <i>P</i> = .042), inotrope need (RR .84, <i>P</i> = .045), and non-invasive ventilation (RR, .54; <i>P</i> = .028). However, no differences were observed for 24hr pain score (SMD, -.35; <i>P</i> = .510) or 48hr morphine equivalent consumption (SMD, -1.09; <i>P</i> = .139). Among thoracic surgery patients, there was no difference between OFA and OBA for any of the explored outcomes, including post-operative nausea and vomiting (RR, 0.41; <i>P</i> = .025).</p><p><strong>Conclusion: </strong>Through the first pooled analysis of OBA vs OFA in a cardiothoracic-exclusive cohort, we found no significant difference in any of the pooled outcomes for thoracic surgery patients. Although limited to 2 cardiovascular surgery studies, OFA was associated with significantly reduced postoperative nausea and vomiting, inotrope need, and non-invasive ventilation in these patients. With growing use of OFA in invasive operations, further studies are needed to assess their efficacy and safety in cardiothoracic patients.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"162-170"},"PeriodicalIF":1.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9705753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial and Ethnic Disparities in U.S Children Undergoing Surgery for Congenital Heart Disease: A Narrative Literature Review. 接受先天性心脏病手术的美国儿童的种族和民族差异:叙述性文献综述。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-09-01 Epub Date: 2022-12-14 DOI: 10.1177/10892532221145229
Faith J Ross, Gregory Latham, Lie Tjoeng, Kelly Everhart, Nathalia Jimenez

Congenital Heart Disease (CHD) is a significant source of pediatric morbidity and mortality. As in other fields of medicine, studies have demonstrated racial and ethnic disparities in congenital heart disease outcomes. The cause of these outcome disparities is multifactorial, involving biological, behavioral, environmental, sociocultural, and systemic medical factors. Potential contributors include differences in preoperative illness severity secondary to coexisting medical conditions, differences in the rate of prenatal and early postnatal detection of CHD, and delayed access to care, as well as discrepancies in socioeconomic and insurance status, and systemic disparities in hospital care. Understanding the factors that contribute to these disparities is an essential step towards developing strategies to address them. As stewards of the perioperative surgical home, anesthesiologists have an important role in developing institutional policies that mitigate racial disparities. Here, we provide a thorough narrative review of recent research concerning perioperative factors contributing to surgical outcomes disparities for children of all ages with CHD, examine potentially modifiable contributing factors, discuss avenues for future research, and suggest strategies to address disparities both locally and nationally.

先天性心脏病(CHD)是儿童发病率和死亡率的重要来源。与其他医学领域一样,研究表明,先天性心脏病结果存在种族和民族差异。这些结果差异的原因是多因素的,包括生物学、行为学、环境、社会文化和系统医学因素。潜在的因素包括并存的医疗条件导致的术前疾病严重程度的差异、产前和产后早期CHD检测率的差异、获得护理的延迟,以及社会经济和保险状况的差异,以及医院护理的系统性差异。了解造成这些差异的因素是制定解决这些差异的战略的重要一步。作为围手术期外科之家的管理人员,麻醉师在制定缓解种族差异的制度政策方面发挥着重要作用。在这里,我们对最近关于导致所有年龄段CHD儿童手术结果差异的围手术期因素的研究进行了全面的叙述性回顾,检查了潜在的可改变的影响因素,讨论了未来研究的途径,并提出了解决当地和全国差异的策略。
{"title":"Racial and Ethnic Disparities in U.S Children Undergoing Surgery for Congenital Heart Disease: A Narrative Literature Review.","authors":"Faith J Ross,&nbsp;Gregory Latham,&nbsp;Lie Tjoeng,&nbsp;Kelly Everhart,&nbsp;Nathalia Jimenez","doi":"10.1177/10892532221145229","DOIUrl":"10.1177/10892532221145229","url":null,"abstract":"<p><p>Congenital Heart Disease (CHD) is a significant source of pediatric morbidity and mortality. As in other fields of medicine, studies have demonstrated racial and ethnic disparities in congenital heart disease outcomes. The cause of these outcome disparities is multifactorial, involving biological, behavioral, environmental, sociocultural, and systemic medical factors. Potential contributors include differences in preoperative illness severity secondary to coexisting medical conditions, differences in the rate of prenatal and early postnatal detection of CHD, and delayed access to care, as well as discrepancies in socioeconomic and insurance status, and systemic disparities in hospital care. Understanding the factors that contribute to these disparities is an essential step towards developing strategies to address them. As stewards of the perioperative surgical home, anesthesiologists have an important role in developing institutional policies that mitigate racial disparities. Here, we provide a thorough narrative review of recent research concerning perioperative factors contributing to surgical outcomes disparities for children of all ages with CHD, examine potentially modifiable contributing factors, discuss avenues for future research, and suggest strategies to address disparities both locally and nationally.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"224-234"},"PeriodicalIF":1.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10330830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Left-Sided Double-Lumen Tube vs EZ-Blocker for One-Lung Ventilation in Thoracic Surgery: A Systematic Review and Meta-Analysis. 左侧双腔管与EZ封堵器用于胸外科单肺通气的系统评价和荟萃分析。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-09-01 Epub Date: 2023-06-22 DOI: 10.1177/10892532231184781
Nicolas Kumar, Justin Mitchell, Andrew Siemens, Selina Deiparine, Daniel Saddawi-Konefka, Nasir Hussain, Manoj H Iyer, Michael Essandoh, Tamara R Sawyer, David Hao

Background. The EZ-Blocker is the newest generation of bronchial blocker and offers a potential alternative to left-sided double lumen tubes for lung isolation and one-lung ventilation during thoracic surgery. Methods. Databases were searched for randomized controlled trials comparing left-sided double lumen tube to the EZ-Blocker for one-lung ventilation during thoracic surgery. The time for placement, incidence of intraoperative displacement, and surgeons' rating of lung collapse quality were designated as coprimary outcomes. The safety profiles of the two devices, including the incidence of airway trauma and post-extubation discomfort were also examined. Results. Six randomized controlled trials (495 patients) were analyzed. Compared to the EZ-Blocker, the left-sided double lumen tube was faster to place by a weighted mean difference of [95% CI] of -61.24 seconds [-102.48, -20.00] (P = .004) and was much less likely to become displaced during lung isolation with an odds ratio [95% CI] of .56 [.34, .91] (P = .02). The left-sided double lumen tube and the EZ-Blocker provided similar surgeon-rated quality of lung isolation. Although the left-sided double lumen tube caused a greater degree of post-extubation sore throat, there was a similar incidence of carinal trauma and post-extubation hoarseness compared to the EZ-Blocker. Conclusion. Our analysis suggests that the left-sided double lumen tube can be placed more quickly and is less prone to intraoperative displacement compared to the EZ-Blocker; the quality of lung collapse is similar. Thus, evidence appears to support the continued utilization of the left-sided double lumen tube for routine thoracic surgery requiring one-lung ventilation.

背景EZ阻断剂是最新一代支气管阻断剂,为胸部手术中的肺部隔离和单肺通气提供了一种潜在的替代左侧双腔管的选择。方法。在数据库中搜索随机对照试验,比较左侧双腔管和EZ阻滞剂在胸部手术中单肺通气的效果。放置时间、术中移位的发生率和外科医生对肺塌陷质量的评分被指定为共同的主要结果。还检查了这两种装置的安全性,包括气道创伤和拔管后不适的发生率。后果对6项随机对照试验(495名患者)进行了分析。与EZ阻断器相比,左侧双腔管的放置速度更快,加权平均差[95%CI]为-61.24秒[102.48,-20.00](P=.004),在肺部隔离期间移位的可能性更小,比值比[95%CI]为.56[.34,.91](P=.02)。左侧双腔导管和EZ-Blocker提供了类似的外科医生评定的肺部隔离质量。尽管左侧双腔管引起拔管后更大程度的喉咙痛,但与EZ阻滞剂相比,隆突创伤和拔管后声音嘶哑的发生率相似。结论我们的分析表明,与EZ封堵器相比,左侧双腔管可以更快地放置,并且不太容易发生术中移位;肺塌陷的质量是相似的。因此,似乎有证据支持在需要单肺通气的常规胸部手术中继续使用左侧双腔管。
{"title":"Left-Sided Double-Lumen Tube vs EZ-Blocker for One-Lung Ventilation in Thoracic Surgery: A Systematic Review and Meta-Analysis.","authors":"Nicolas Kumar,&nbsp;Justin Mitchell,&nbsp;Andrew Siemens,&nbsp;Selina Deiparine,&nbsp;Daniel Saddawi-Konefka,&nbsp;Nasir Hussain,&nbsp;Manoj H Iyer,&nbsp;Michael Essandoh,&nbsp;Tamara R Sawyer,&nbsp;David Hao","doi":"10.1177/10892532231184781","DOIUrl":"10.1177/10892532231184781","url":null,"abstract":"<p><p><i>Background.</i> The EZ-Blocker is the newest generation of bronchial blocker and offers a potential alternative to left-sided double lumen tubes for lung isolation and one-lung ventilation during thoracic surgery. <i>Methods.</i> Databases were searched for randomized controlled trials comparing left-sided double lumen tube to the EZ-Blocker for one-lung ventilation during thoracic surgery. The time for placement, incidence of intraoperative displacement, and surgeons' rating of lung collapse quality were designated as coprimary outcomes. The safety profiles of the two devices, including the incidence of airway trauma and post-extubation discomfort were also examined. <i>Results.</i> Six randomized controlled trials (495 patients) were analyzed. Compared to the EZ-Blocker, the left-sided double lumen tube was faster to place by a weighted mean difference of [95% CI] of -61.24 seconds [-102.48, -20.00] (P = .004) and was much less likely to become displaced during lung isolation with an odds ratio [95% CI] of .56 [.34, .91] (P = .02). The left-sided double lumen tube and the EZ-Blocker provided similar surgeon-rated quality of lung isolation. Although the left-sided double lumen tube caused a greater degree of post-extubation sore throat, there was a similar incidence of carinal trauma and post-extubation hoarseness compared to the EZ-Blocker. <i>Conclusion.</i> Our analysis suggests that the left-sided double lumen tube can be placed more quickly and is less prone to intraoperative displacement compared to the EZ-Blocker; the quality of lung collapse is similar. Thus, evidence appears to support the continued utilization of the left-sided double lumen tube for routine thoracic surgery requiring one-lung ventilation.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"171-180"},"PeriodicalIF":1.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9677278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cardiac Surgeons Highlight the Need for Innovation Stewardship: Noteworthy in 2022. 心脏外科医生强调创新管理的必要性:2022年值得注意。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-06-01 DOI: 10.1177/10892532231173090
Adom Netsanet, Jake Cotton, Alejandro Suarez-Pierre, Jordan Hoffman, Muhammad Aftab, Brett Reece, Jessica Y Rove

Modern cardiac surgery has rapidly evolved to treat complex cardiovascular disease. This past year boasted noteworthy advances in xenotransplantation, prosthetic cardiac valves, and endovascular thoracic aortic repair. Newer devices often offer incremental design changes while demanding significant cost increases that leave surgeons to decide if the benefit to patients justifies the increased cost. As innovations are introduced, surgeons must continuously aim to harmonize short- and long-term benefits with financial costs). We must also ensure quality patient outcomes while embracing innovations that will advance equitable cardiovascular care.

现代心脏外科手术已迅速发展到治疗复杂的心血管疾病。在过去的一年里,异种移植、人工心脏瓣膜和血管内胸主动脉修复方面取得了显著进展。较新的设备通常会在要求大幅增加成本的同时进行渐进式的设计更改,这让外科医生决定患者的利益是否值得增加成本。随着创新的引入,外科医生必须不断努力协调短期和长期效益与财务成本。我们还必须确保患者获得高质量的治疗结果,同时接受将促进公平心血管护理的创新。
{"title":"Cardiac Surgeons Highlight the Need for Innovation Stewardship: Noteworthy in 2022.","authors":"Adom Netsanet,&nbsp;Jake Cotton,&nbsp;Alejandro Suarez-Pierre,&nbsp;Jordan Hoffman,&nbsp;Muhammad Aftab,&nbsp;Brett Reece,&nbsp;Jessica Y Rove","doi":"10.1177/10892532231173090","DOIUrl":"https://doi.org/10.1177/10892532231173090","url":null,"abstract":"<p><p>Modern cardiac surgery has rapidly evolved to treat complex cardiovascular disease. This past year boasted noteworthy advances in xenotransplantation, prosthetic cardiac valves, and endovascular thoracic aortic repair. Newer devices often offer incremental design changes while demanding significant cost increases that leave surgeons to decide if the benefit to patients justifies the increased cost. As innovations are introduced, surgeons must continuously aim to harmonize short- and long-term benefits with financial costs). We must also ensure quality patient outcomes while embracing innovations that will advance equitable cardiovascular care.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"27 2","pages":"136-144"},"PeriodicalIF":1.4,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Abdominal Organ Transplantation: Noteworthy Literature in 2022. 腹部器官移植:2022年值得关注的文献。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-06-01 DOI: 10.1177/10892532231169075
Lyle Nolasco, Divya Igwe, Natalie K Smith, Tetsuro Sakai

This review highlights noteworthy literature published in 2022 pertinent to anesthesiologists and critical care physicians caring for patients undergoing abdominal organ transplantation. We begin by exploring the impacts that the COVID-19 pandemic has had across the field of abdominal organ transplantation, including the successful use of grafts procured from COVID-19-infected donors. In pancreatic transplantation, we highlight several studies on dexmedetomidine and ischemia-reperfusion injury, equity in transplantation, and medical management, as well as studies comparing pancreatic transplantation to islet cell transplantation. In our section on intestinal transplantation, we explore donor selection. Kidney transplantation topics include cardiovascular risk management, obesity, and intraoperative management, including fluid resuscitation, dexmedetomidine, and sugammadex. The liver transplantation section focuses on clinical trials, systematic reviews, and meta-analyses published in 2022 and covers a wide range of topics, including machine perfusion, cardiovascular issues, renal issues, and coagulation/transfusion.

本综述重点介绍了2022年发表的与麻醉医师和重症监护医师护理腹部器官移植患者相关的值得注意的文献。我们首先探讨COVID-19大流行对腹部器官移植领域的影响,包括成功使用感染COVID-19的捐赠者的移植物。在胰腺移植方面,我们重点介绍了几项关于右美托咪定与缺血再灌注损伤、移植公平性和医疗管理的研究,以及胰腺移植与胰岛细胞移植的比较研究。在肠移植部分,我们探讨了供体的选择。肾移植的主题包括心血管风险管理、肥胖和术中管理,包括液体复苏、右美托咪定和糖马德。肝移植部分侧重于临床试验、系统综述和荟萃分析,发表于2022年,涵盖了广泛的主题,包括机器灌注、心血管问题、肾脏问题和凝血/输血。
{"title":"Abdominal Organ Transplantation: Noteworthy Literature in 2022.","authors":"Lyle Nolasco,&nbsp;Divya Igwe,&nbsp;Natalie K Smith,&nbsp;Tetsuro Sakai","doi":"10.1177/10892532231169075","DOIUrl":"https://doi.org/10.1177/10892532231169075","url":null,"abstract":"<p><p>This review highlights noteworthy literature published in 2022 pertinent to anesthesiologists and critical care physicians caring for patients undergoing abdominal organ transplantation. We begin by exploring the impacts that the COVID-19 pandemic has had across the field of abdominal organ transplantation, including the successful use of grafts procured from COVID-19-infected donors. In pancreatic transplantation, we highlight several studies on dexmedetomidine and ischemia-reperfusion injury, equity in transplantation, and medical management, as well as studies comparing pancreatic transplantation to islet cell transplantation. In our section on intestinal transplantation, we explore donor selection. Kidney transplantation topics include cardiovascular risk management, obesity, and intraoperative management, including fluid resuscitation, dexmedetomidine, and sugammadex. The liver transplantation section focuses on clinical trials, systematic reviews, and meta-analyses published in 2022 and covers a wide range of topics, including machine perfusion, cardiovascular issues, renal issues, and coagulation/transfusion.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"27 2","pages":"97-113"},"PeriodicalIF":1.4,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9534837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Year in Review: Anesthesia for Congenital Heart Disease 2022. 年度回顾:麻醉治疗先天性心脏病2022。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-06-01 DOI: 10.1177/10892532231173801
Matthew M Goodmanson, Gregory J Latham, Leah M Landsem, Faith J Ross

This review focuses on the literature published during the calendar year 2022 that is of interest to anesthesiologists taking care of children and adults with congenital heart disease (CHD). Four major themes are discussed: enhanced recovery after surgery(ERAS); diversity, equity, and inclusion; the state of pediatric cardiac anesthesiology as a subspecialty in the United States; and neuromonitoring for pediatric cardiac surgery.

本综述的重点是在2022日历年期间发表的文献,这些文献对麻醉医师照顾患有先天性心脏病(CHD)的儿童和成人感兴趣。讨论了四个主要主题:增强术后恢复(ERAS);多样性、公平和包容;美国儿科心脏麻醉学作为亚专科的现状;以及小儿心脏手术的神经监测。
{"title":"The Year in Review: Anesthesia for Congenital Heart Disease 2022.","authors":"Matthew M Goodmanson,&nbsp;Gregory J Latham,&nbsp;Leah M Landsem,&nbsp;Faith J Ross","doi":"10.1177/10892532231173801","DOIUrl":"https://doi.org/10.1177/10892532231173801","url":null,"abstract":"<p><p>This review focuses on the literature published during the calendar year 2022 that is of interest to anesthesiologists taking care of children and adults with congenital heart disease (CHD). Four major themes are discussed: enhanced recovery after surgery(ERAS); diversity, equity, and inclusion; the state of pediatric cardiac anesthesiology as a subspecialty in the United States; and neuromonitoring for pediatric cardiac surgery.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"27 2","pages":"114-122"},"PeriodicalIF":1.4,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9907031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Year 2022 in Review and a Glimpse into the Future. 回顾2022年,展望未来。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-06-01 DOI: 10.1177/10892532231178860
Eric Leiendecker, Dan Viox, Miklos D Kertai, Benjamin Abrams
Innovation has consistently been the hallmark of progress in the care of cardiac surgery and transplant patients— forward thinking in hopes of creating a better future. From the moment Ludwig Rehn sutured a myocardial laceration in 1896, or in 1954 when Joseph Murray performed the first successful solid organ transplant, there has been a clear eye towards the future and using innovative means of tackling the problems we see before us. The year 2022 was no exception, with a major advance made in xenotransplantation with a cardiac graft that functioned adequately for 7 weeks after implantation, as 1 example. Many such advancements are highlighted in this issue of Seminars in Cardiothoracic and Vascular Anesthesia, which compiles a series of review articles summarizing the notable research and innovations from this past year. The relevant publications have been divided into 5 separate categories for the reader, including critical care medicine, abdominal transplantation, congenital heart disease, cardiac anesthesia, and cardiac surgery. It was a busy year in critical care medicine and Alber et al have done a wonderful job summarizing the advancements made in the care of post-cardiac arrest patients, resuscitation, mechanical ventilation, septic shock, and nutritional support, as well as improving neurologic outcomes in the critically ill. The use of VA-ECMO as a means of rescue in the care of post-cardiac arrest patients has gained more attention this year, where there has been a focus towards temperature management and cytokine adsorption. Additionally, following the COVID-19 pandemic there was work done describing the neurocognitive outcomes of ECMO survivors. Building on prior work done evaluating the utility of targeted temperature management (TTM), the HYPO-ECMO group randomized patients with cardiac arrest or refractory cardiogenic shock that received ECLS to either moderate hypothermia (33-34°C) or normothermia (36-37°C) finding a non-statistically significant differences in the primary outcome of 30 day mortality though the composite outcome of death, or escalation to LVAD or heart transplant at 30 days favored the mild hypothermia group, and importantly there were no increased risks of adverse events in the mild hypothermia group. Post-cardiac arrest syndrome (PCAS) is a well-established inflammatory condition following ROSC that results in ischemia-reperfusion injury and the release of proinflammatory cytokines, such as interleukin-6 (IL-6). The CYTER Trial Group utilized a hemoadsorber in the ECMO circuit at the time of VA ECMO cannulation in the setting of ECPR, postulating that it maymitigate reperfusion injury at the time of cannulation. There was not a statistically significant fall in the IL-6 levels or any differences in a host of secondary outcomes, including mortality and SOFA score, though this single-center study was limited by a relatively small and heterogeneous population. Fernando et al added additional insight into neurocog
{"title":"The Year 2022 in Review and a Glimpse into the Future.","authors":"Eric Leiendecker,&nbsp;Dan Viox,&nbsp;Miklos D Kertai,&nbsp;Benjamin Abrams","doi":"10.1177/10892532231178860","DOIUrl":"https://doi.org/10.1177/10892532231178860","url":null,"abstract":"Innovation has consistently been the hallmark of progress in the care of cardiac surgery and transplant patients— forward thinking in hopes of creating a better future. From the moment Ludwig Rehn sutured a myocardial laceration in 1896, or in 1954 when Joseph Murray performed the first successful solid organ transplant, there has been a clear eye towards the future and using innovative means of tackling the problems we see before us. The year 2022 was no exception, with a major advance made in xenotransplantation with a cardiac graft that functioned adequately for 7 weeks after implantation, as 1 example. Many such advancements are highlighted in this issue of Seminars in Cardiothoracic and Vascular Anesthesia, which compiles a series of review articles summarizing the notable research and innovations from this past year. The relevant publications have been divided into 5 separate categories for the reader, including critical care medicine, abdominal transplantation, congenital heart disease, cardiac anesthesia, and cardiac surgery. It was a busy year in critical care medicine and Alber et al have done a wonderful job summarizing the advancements made in the care of post-cardiac arrest patients, resuscitation, mechanical ventilation, septic shock, and nutritional support, as well as improving neurologic outcomes in the critically ill. The use of VA-ECMO as a means of rescue in the care of post-cardiac arrest patients has gained more attention this year, where there has been a focus towards temperature management and cytokine adsorption. Additionally, following the COVID-19 pandemic there was work done describing the neurocognitive outcomes of ECMO survivors. Building on prior work done evaluating the utility of targeted temperature management (TTM), the HYPO-ECMO group randomized patients with cardiac arrest or refractory cardiogenic shock that received ECLS to either moderate hypothermia (33-34°C) or normothermia (36-37°C) finding a non-statistically significant differences in the primary outcome of 30 day mortality though the composite outcome of death, or escalation to LVAD or heart transplant at 30 days favored the mild hypothermia group, and importantly there were no increased risks of adverse events in the mild hypothermia group. Post-cardiac arrest syndrome (PCAS) is a well-established inflammatory condition following ROSC that results in ischemia-reperfusion injury and the release of proinflammatory cytokines, such as interleukin-6 (IL-6). The CYTER Trial Group utilized a hemoadsorber in the ECMO circuit at the time of VA ECMO cannulation in the setting of ECPR, postulating that it maymitigate reperfusion injury at the time of cannulation. There was not a statistically significant fall in the IL-6 levels or any differences in a host of secondary outcomes, including mortality and SOFA score, though this single-center study was limited by a relatively small and heterogeneous population. Fernando et al added additional insight into neurocog","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"27 2","pages":"81-86"},"PeriodicalIF":1.4,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9993453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Year in Review 2022: Noteworthy Literature in Cardiac Anesthesiology. 2022年回顾:心脏麻醉学值得关注的文献。
IF 1.4 Q3 ANESTHESIOLOGY Pub Date : 2023-06-01 DOI: 10.1177/10892532231173074
Elijah Christensen, Joseph Morabito, Markus Kowalsky, John-Paul Tsai, Douglas Rooke, Nathan Clendenen

Last year researchers made substantial progress in work relevant to the practice of cardiac anesthesiology. We reviewed 389 articles published in 2022 focused on topics related to clinical practice to identify 16 that will impact the current and future practice of cardiac anesthesiology. We identified 4 broad themes including risk prediction, postoperative outcomes, clinical practice, and technological advances. These articles are representative of the best work in our field in 2022.

去年,研究人员在与心脏麻醉学实践相关的工作上取得了实质性进展。我们回顾了2022年发表的389篇与临床实践相关的文章,确定了16篇将影响心脏麻醉学当前和未来实践的文章。我们确定了4大主题,包括风险预测、术后结果、临床实践和技术进步。这些文章代表了2022年我们领域的优秀作品。
{"title":"Year in Review 2022: Noteworthy Literature in Cardiac Anesthesiology.","authors":"Elijah Christensen,&nbsp;Joseph Morabito,&nbsp;Markus Kowalsky,&nbsp;John-Paul Tsai,&nbsp;Douglas Rooke,&nbsp;Nathan Clendenen","doi":"10.1177/10892532231173074","DOIUrl":"https://doi.org/10.1177/10892532231173074","url":null,"abstract":"<p><p>Last year researchers made substantial progress in work relevant to the practice of cardiac anesthesiology. We reviewed 389 articles published in 2022 focused on topics related to clinical practice to identify 16 that will impact the current and future practice of cardiac anesthesiology. We identified 4 broad themes including risk prediction, postoperative outcomes, clinical practice, and technological advances. These articles are representative of the best work in our field in 2022.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"27 2","pages":"123-135"},"PeriodicalIF":1.4,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445401/pdf/nihms-1920352.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10057727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Seminars in Cardiothoracic and Vascular Anesthesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1